SCHEMBL8522281

SCHEMBL8522281

CCN(CC)c1cc(-c2ccc(N)cc2)ccc1N

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.48
TDP1 Q9NUW8 6/20 0.48
CYP3A4 P08684 6/20 0.48
L3MBTL1 Q9Y468 3/20 0.48
TSHR P16473 3/20 0.48
MAPK1 P28482 2/20 0.48
PSMD14 O00487 1/20 0.48
RECQL P46063 1/20 0.48
GFER P55789 1/20 0.48
S100B P04271 1/20 0.42
TP53 P04637 1/20 0.41
HSD17B10 Q99714 4/20 0.39
MAPT P10636 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 2/20 0.39
HPGD P15428 2/20 0.39
POLB P06746 1/20 0.39
TAAR1 Q96RJ0 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5186192 0.84 ALDH1A1 (0.50) ALDH1A1TDP1CYP3A4L3MBTL1TSHR
SCHEMBL3677213 0.79 CYP3A4 (0.46) ALDH1A1TDP1CYP3A4L3MBTL1TSHR
Sulfurous Acid SCHEMBL11524062 0.75 ALDH1A1 (0.41) ALDH1A1TDP1CYP3A4L3MBTL1TSHR
Sulfuric Acid SCHEMBL7809539 0.75 ALDH1A1 (0.49) ALDH1A1TDP1CYP3A4L3MBTL1TSHR
SCHEMBL1341419 0.75 S100B (0.50) ALDH1A1TDP1CYP3A4L3MBTL1TSHR
SCHEMBL1245943 0.75 CYP3A4 (0.46) ALDH1A1TDP1CYP3A4TSHRMAPK1
SCHEMBL8526892 0.74 ALDH1A1 (0.48) ALDH1A1TDP1CYP3A4L3MBTL1TSHR
SCHEMBL2155334 0.74 ALDH1A1 (0.86) ALDH1A1TDP1CYP3A4L3MBTL1TSHR
Hydrochloric Acid SCHEMBL27845061 0.73 S100B (0.48) ALDH1A1TDP1CYP3A4L3MBTL1TSHR
SCHEMBL30702660 0.73 MAPT (0.47) ALDH1A1TDP1CYP3A4S100BHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0625195-B1 THERAPY OF CENTRAL NERVOUS SYSTEM BY GENETICALLY MODIFIED CELLS UNIV CALIFORNIA (US) 1999-01-07 EP disclosed
EP-0491057-B1 HYBRIDOMA WHICH PRODUCES AVIAN SPECIFIC IMMUNOGLOBULIN G NIPPON KOKAN KK (JP) 1998-12-30 EP disclosed
US-5762926-A Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-06-09 US disclosed
US-5650148-A Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1997-07-22 US disclosed
EP-0737743-A1 Thymidine kinase-lacking ouabain-resistant chicken hybridoma NKK CORPORATION (JP) 1996-10-16 EP disclosed
EP-0625195-A1 THERAPY OF CENTRAL NERVOUS SYSTEM BY GENETICALLY MODIFIED CELLS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1994-11-23 EP disclosed
WO-1993010234-A1 THERAPY OF CENTRAL NERVOUS SYSTEM BY GENETICALLY MODIFIED CELLS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1993-05-27 WO disclosed
EP-0491057-A1 HYBRIDOMA WHICH PRODUCES AVIAN SPECIFIC IMMUNOGLOBULIN G NKK CORPORATION (JP) 1992-06-24 EP disclosed
US-5095094-A A43 kDa antigenic protein of Bordetella recognized by polyclonal antibodies to adenylate cyclase but devoid of calmodulin-activatable adenylate cyclase activity INSTITUT PASTEUR (FR) 1992-03-10 US disclosed
EP-0338170-A1 Immunoprotective antigenic protein against pathogenic bacteria INSTITUT PASTEUR (FR) 1989-10-25 EP disclosed